“Maintaining a safe and adequate supply of blood and blood products in the U.S. is paramount for the FDA, and this proposal for an individual risk assessment, regardless of gender or sexual orientation, will enable us to continue using the best science to do so,” […]
The Centers for Disease Control and Prevention on Friday urged people with weak immune systems to take extra precautions to avoid Covid after the dominant omicron subvariants knocked out a key antibody treatment. These precautions include wearing a high quality mask and social distancing when […]
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Continue to be cautious Buy Eli Lilly Meta needs more cost cuts 1. Continue to be cautious Stocks edged up […]
The Food and Drug Administration on Thursday pulled its authorization for AstraZeneca‘s Evusheld, an antibody injection that people with weak immune systems relied on for additional protection against Covid-19. The FDA pulled Evusheld from the market because it is not effective against more than 90% […]
WATCH LIVE The Food and Drug Administration hasn’t found an increased risk of stroke for seniors who’ve received Pfizer’s omicron booster shot, a federal health official said Thursday. The FDA launched an extensive review of federal data after investigators at the Centers for Disease Control […]
The Food and Drug Administration’s independent advisory committee on Thursday recommended replacing Pfizer and Moderna’s original Covid vaccine used in the U.S. for everyone’s first two immunizations with the new bivalent omicron shots. If the FDA accepts the advisors’ recommendation, the U.S. would likely phase […]
